跳至主要内容
临床试验/CTRI/2024/02/063329
CTRI/2024/02/063329尚未招募4 期

Randomized, Double-blind, Placebo-controlled, Pilot Study of Add-on Beta Sitosterol Supplementation on Treatment Response in Prostate Cancer Patients - NI

AIIMS New Delhi0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • •1. Males, age=18 years
  • •2. Histologically proven prostate adenocarcinoma
  • •3.Metastatic prostate cancer on ADT+/- Abiraterone acetate +/- Chemotherapy +/- Antiandrogen

排除标准

  • •1. Brain or Leptomeningeal metastasis
  • •2. Bilirubin, AST or ALT more than 2.5 times of the upper limit of normal levels.
  • •3. Currently active Inflammatory bowel disease or Inflammatory bowel syndrome
  • •4. History of any other malignancy in the last five years
  • •5. History of recent surgery within 4 weeks of enrolment
  • •6. Patients who are not willing to participate and will not provide signed informed consent

研究者

发起方
AIIMS New Delhi

相似试验